title: Minimally invasive treatment of pilonidal disease: crystallized phenol and laser depilation.
abstract: Pilonidal disease has been treated surgically and by various other methods for many years. The most important problem associated with such treatment is recurrence, but cosmetic outcome is another important issue that cannot be ignored. Today, crystallized phenol is recognized as a treatment option associated with good medical and cosmetic outcomes. We hypothesized that the addition of laser depilation to crystallized phenol treatment of pilonidal disease might increase the rate of success, and this study aimed to determine if the hypothesis was true. Patients who were treated with crystallized phenol and 755-nm alexandrite laser depilation were retrospectively analyzed. In total, 42 (31 male and 11 female) patients were treated with crystallized phenol and alexandrite laser depilation and were followed up between January 2009 and January 2012. In all, 38 patients (90.5%) had chronic disease and 4 (9.5%) had recurrent disease. Among the patients, 26 (61.9%) recovered following 1 crystallized phenol treatment, and the remaining patients had complete remission following repeated treatment. Some patients needed multiple treatments, even up to 8 times. None of the patients had a recurrence during a mean 24 months (range, 6-30 months) of follow-up. Whatever method of treatment is used for pilonidal disease, hair cleaning positively affects treatment outcome. The present results support the hypothesis that the addition of laser depilation (which provides more permanent and effective depilation than other methods) to crystallized phenol treatment (a non-radical, minimally invasive method associated with very good cosmetic results) can increase the effectiveness of the treatment and also reduce the recurrence rate of the disease.
authors.affiliation: 1 Department of General Surgery, Faculty of Medicine, Firat University, Elazig, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Girgin
authors.forename: Burhan Hakan
authors.initials: BH
authors.lastname: Kanat
authors.forename: Refik
authors.initials: R
authors.lastname: Ayten
authors.forename: Ziya
authors.initials: Z
authors.lastname: Cetinkaya
authors.forename: Zekiye
authors.initials: Z
authors.lastname: Kanat
authors.forename: Ahmet
authors.initials: A
authors.lastname: Bozdağ
authors.forename: Ahmet
authors.initials: A
authors.lastname: Turkoglu
authors.forename: Yavuz Selim
authors.initials: YS
authors.lastname: Ilhan
mesh_terms: D000293:Adolescent; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003460:Crystallization; D005260:Female; D005500:Follow-Up Studies; D006204:Hair Removal / Q000379:methods*; D006801:Humans; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D008297:Male; D019800:Phenol / Q000627:therapeutic use*; D010864:Pilonidal Sinus / Q000628:therapy*; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000891:Anti-Infective Agents, Local; D019800:Phenol